Helen Allvin

Helen Allvin serves as the Global Patient Advocacy Lead at Orion Corporation since January 2023, following a tenure as Patient Advocacy Group Manager at Orion Pharma Corp. from July 2020 to January 2023. With a career at Orion Corporation spanning over two decades, Helen has held various roles including Global Brand Manager for CNS/ALS and dexdor, where responsibilities included the European launch of the alfa2agonist dexdor across 27 countries. Previous positions include Business Manager for Simdax and Dexmedetomidine and Area Manager for Critical Care. Earlier career experience includes roles at Bayer HealthCare and Jansen Cilag as a Product Specialist. Educational credentials feature a degree in Marketing Economical Education from Sensus, Jönköping, and training in strategy and leadership.